Mark J. Enyedy, CHIEF EXECUTIVE OFFICER at ImmunoGen, Inc. (IMGN), sold 4,995,108 shares at $16.61 ($85.3M) on 2023-08-03, disclosed to the SEC on 2023-08-04.
Open-market sale of $85.3M IMGN by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.45 | 986,521 | $17.2M | 20.2% |
| 2 | $17.45 | 986,521 | $17.2M | 20.2% |
| 3 | $18.15 | 8,636 | $157K | 0.2% |
| 4 | $18.15 | 8,636 | $157K | 0.2% |
| 5 | $16.61 | 1,020,000 | $16.9M | 19.9% |
| 6 | $16.96 | 992,397 |
| $16.8M |
| 19.7% |
| 7 | $16.96 | 992,397 | $16.8M | 19.7% |
| Total | $17.09 avg | 4,995,108 | $85.3M | 100% |
| Filing → |
| IMGN | SELL | 2019-02-25 | $286K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $1.5M | — | Filing → |
| IMGN | BUY | 2016-11-09 | $46K | — | Filing → |